Search filters

List of works by Dongmun Ha

Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real-world evidence using a nationwide database.

scientific article published on 17 April 2018

Paulina is supported by:

About Paulina

Help